Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hi-Tech Pharmacal has announced that the FDA has granted final approval to the company's abbreviated new drug application for ofloxacin otic solution, 0.3%.
Subscribe to our email newsletter
Hi-Tech’s ofloxacin otic solution is the generic equivalent of Daiichi’s Floxin otic solution, 0.3% indicated for the treatment of bacterial infections of the ear which in 2007, had sales of $105 million according to IMS.